192 related articles for article (PubMed ID: 26318558)
1. Simultaneous staining of sputum smears for acid-fast and lipid-containing Myobacterium tuberculosis can enhance the clinical evaluation of antituberculosis treatments.
Kayigire XA; Friedrich SO; van der Merwe L; Donald PR; Diacon AH
Tuberculosis (Edinb); 2015 Dec; 95(6):770-779. PubMed ID: 26318558
[TBL] [Abstract][Full Text] [Related]
2. Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis.
Botha FJ; Sirgel FA; Parkin DP; van de Wal BW; Donald PR; Mitchison DA
S Afr Med J; 1996 Feb; 86(2):155-8. PubMed ID: 8619142
[TBL] [Abstract][Full Text] [Related]
3. The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis.
Chan SL; Yew WW; Ma WK; Girling DJ; Aber VR; Felmingham D; Allen BW; Mitchison DA
Tuber Lung Dis; 1992 Feb; 73(1):33-8. PubMed ID: 1326348
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamic Modeling of Bacillary Elimination Rates and Detection of Bacterial Lipid Bodies in Sputum to Predict and Understand Outcomes in Treatment of Pulmonary Tuberculosis.
Sloan DJ; Mwandumba HC; Garton NJ; Khoo SH; Butterworth AE; Allain TJ; Heyderman RS; Corbett EL; Barer MR; Davies GR
Clin Infect Dis; 2015 Jul; 61(1):1-8. PubMed ID: 25778753
[TBL] [Abstract][Full Text] [Related]
5. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears.
Diacon AH; Patientia RF; Venter A; van Helden PD; Smith PJ; McIlleron H; Maritz JS; Donald PR
Antimicrob Agents Chemother; 2007 Aug; 51(8):2994-6. PubMed ID: 17517849
[TBL] [Abstract][Full Text] [Related]
6. Serial image analysis of Mycobacterium tuberculosis colony growth reveals a persistent subpopulation in sputum during treatment of pulmonary TB.
Barr DA; Kamdolozi M; Nishihara Y; Ndhlovu V; Khonga M; Davies GR; Sloan DJ
Tuberculosis (Edinb); 2016 May; 98():110-5. PubMed ID: 27156626
[TBL] [Abstract][Full Text] [Related]
7. Comparison of time to positive and colony counting in an early bactericidal activity study of anti-tuberculosis treatment.
Bark CM; Gitta P; Ogwang S; Nsereko M; Thiel BA; Boom WH; Eisenach KD; Joloba ML; Johnson JL
Int J Tuberc Lung Dis; 2013 Nov; 17(11):1448-51. PubMed ID: 24125449
[TBL] [Abstract][Full Text] [Related]
8. Time to positivity in liquid culture predicts colony forming unit counts of Mycobacterium tuberculosis in sputum specimens.
Diacon AH; van der Merwe L; Demers AM; von Groote-Bidlingmaier F; Venter A; Donald PR
Tuberculosis (Edinb); 2014 Mar; 94(2):148-51. PubMed ID: 24456754
[TBL] [Abstract][Full Text] [Related]
9. The early bactericidal activity of anti-tuberculosis drugs: a literature review.
Donald PR; Diacon AH
Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S75-83. PubMed ID: 18762155
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis. A single-blind randomized evaluation in Ugandan patients with HIV-1 infection and pulmonary tuberculosis.
Schwander S; Rüsch-Gerdes S; Mateega A; Lutalo T; Tugume S; Kityo C; Rubaramira R; Mugyenyi P; Okwera A; Mugerwa R
Tuber Lung Dis; 1995 Jun; 76(3):210-8. PubMed ID: 7548903
[TBL] [Abstract][Full Text] [Related]
11. The evaluation of anti-tuberculosis drug effects on phenotypes of Mycobacterium tuberculosis not detected by culture methods.
Kayigire XA; Friedrich SO; van der Merwe L; Diacon AH
Tuberculosis (Edinb); 2019 May; 116():32-34. PubMed ID: 31153515
[No Abstract] [Full Text] [Related]
12. Differentially Detectable Mycobacterium tuberculosis Cells in Sputum from Treatment-Naive Subjects in Haiti and Their Proportionate Increase after Initiation of Treatment.
McAulay K; Saito K; Warrier T; Walsh KF; Mathurin LD; Royal-Mardi G; Lee MH; Ocheretina O; Pape JW; Fitzgerald DW; Nathan CF
mBio; 2018 Nov; 9(6):. PubMed ID: 30459198
[TBL] [Abstract][Full Text] [Related]
13. Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs.
Nikonenko BV; Protopopova M; Samala R; Einck L; Nacy CA
Antimicrob Agents Chemother; 2007 Apr; 51(4):1563-5. PubMed ID: 17242141
[TBL] [Abstract][Full Text] [Related]
14. Improving acid-fast fluorescent staining for the detection of mycobacteria using a new nucleic acid staining approach.
Ryan GJ; Shapiro HM; Lenaerts AJ
Tuberculosis (Edinb); 2014 Sep; 94(5):511-8. PubMed ID: 25130623
[TBL] [Abstract][Full Text] [Related]
15. Time to detection of the growth of Mycobacterium tuberculosis in MGIT 960 for determining the early bactericidal activity of antituberculosis agents.
Diacon AH; Maritz JS; Venter A; van Helden PD; Andries K; McNeeley DF; Donald PR
Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1561-5. PubMed ID: 20820832
[TBL] [Abstract][Full Text] [Related]
16. Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy.
Desjardin LE; Perkins MD; Wolski K; Haun S; Teixeira L; Chen Y; Johnson JL; Ellner JJ; Dietze R; Bates J; Cave MD; Eisenach KD
Am J Respir Crit Care Med; 1999 Jul; 160(1):203-10. PubMed ID: 10390401
[TBL] [Abstract][Full Text] [Related]
17. Serial measurements of transrenal mycobacterial DNA as indicators of the early bactericidal activity (EBA) of antituberculosis drugs.
Heyckendorf J; Labugger I; van der Merwe L; Garcia-Basteiro AL; Diacon AH; Lange C
Tuberculosis (Edinb); 2017 Jan; 102():31-33. PubMed ID: 28061950
[No Abstract] [Full Text] [Related]
18. Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis.
Walter ND; Dolganov GM; Garcia BJ; Worodria W; Andama A; Musisi E; Ayakaka I; Van TT; Voskuil MI; de Jong BC; Davidson RM; Fingerlin TE; Kechris K; Palmer C; Nahid P; Daley CL; Geraci M; Huang L; Cattamanchi A; Strong M; Schoolnik GK; Davis JL
J Infect Dis; 2015 Sep; 212(6):990-8. PubMed ID: 25762787
[TBL] [Abstract][Full Text] [Related]
19. Sputum Mycobacterium tuberculosis mRNA as a marker of bacteriologic clearance in response to antituberculosis therapy.
Li L; Mahan CS; Palaci M; Horter L; Loeffelholz L; Johnson JL; Dietze R; Debanne SM; Joloba ML; Okwera A; Boom WH; Eisenach KD
J Clin Microbiol; 2010 Jan; 48(1):46-51. PubMed ID: 19923475
[TBL] [Abstract][Full Text] [Related]
20. A continuously monitored colorimetric method for detection of Mycobacterium tuberculosis complex in sputum.
Rojas-Ponce G; Rachow A; Guerra H; Mapamba D; Joseph J; Mlundi R; Marimoto S; Ntinginya NE; Mangu C; Framhein A; Butler A; Kohlenberg A; Ngatemelela D; Froeschl G; Maboko L; Hoelscher M; Heinrich N
Int J Tuberc Lung Dis; 2013 Dec; 17(12):1607-12. PubMed ID: 24200277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
